Vir Biotechnology (VIR) Payables (2018 - 2026)
Vir Biotechnology's Payables was $11.32 million in Q3 2026, up 65.4% from $6.85 million a year earlier but down 36.2% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, Payables at Vir Biotechnology came in at $9.8 million, up 92.9% from FY2024.
- Payables shows a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
- In earlier years, Payables was $5.08 million in FY2024 (-19.8%), $6.33 million in FY2023 (-1.4%), $6.42 million in FY2022 (-1.5%) and $6.52 million in FY2021 (+28.4%).
- Quarterly Payables has moved between $2.72 million (Q3 2022) and $17.75 million (Q2 2026) over five years.
- Compared with a year earlier, Payables has increased for four straight quarters, with growth averaging 44.3% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q1 2022 (growth of 196.0%); the worst was Q2 2024 (a decline of 64.5%).
- Per Business Quant data, VIR's Payables in the three quarters before Q3 2026 was $17.75 million (Q2 2026), $5.45 million (Q1 2026) and $9.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Vir Biotechnology | 2.28 Bn | 363.84 Mn | 188,000.00 | 11.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.32 Mn |
| Jun 30, 2026 | 17.75 Mn |
| Mar 31, 2026 | 5.45 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Sep 30, 2025 | 6.85 Mn |
| Jun 30, 2025 | 12.23 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 5.08 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 4.39 Mn |
| Mar 31, 2024 | 7.11 Mn |
| Dec 31, 2023 | 6.33 Mn |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 12.36 Mn |
| Mar 31, 2023 | 12.15 Mn |
| Dec 31, 2022 | 6.42 Mn |
| Sep 30, 2022 | 2.72 Mn |
| Jun 30, 2022 | 10.62 Mn |
| Mar 31, 2022 | 10.96 Mn |
| Dec 31, 2021 | 6.52 Mn |
API Access
Vir Biotechnology Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();